Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biomerica (BMRA) Revenue (2016 - 2025)

Historic Revenue for Biomerica (BMRA) over the last 16 years, with Q4 2025 value amounting to $1.2 million.

  • Biomerica's Revenue fell 2603.91% to $1.2 million in Q4 2025 from the same period last year, while for Nov 2025 it was $4.5 million, marking a year-over-year decrease of 2005.02%. This contributed to the annual value of $5.3 million for FY2025, which is 192.06% down from last year.
  • Per Biomerica's latest filing, its Revenue stood at $1.2 million for Q4 2025, which was down 2603.91% from $1.4 million recorded in Q3 2025.
  • Biomerica's Revenue's 5-year high stood at $7.7 million during Q1 2022, with a 5-year trough of $749000.0 in Q2 2025.
  • Over the past 5 years, Biomerica's median Revenue value was $1.4 million (recorded in 2022), while the average stood at $2.1 million.
  • As far as peak fluctuations go, Biomerica's Revenue surged by 40300.53% in 2022, and later plummeted by 8549.7% in 2023.
  • Biomerica's Revenue (Quarter) stood at $4.6 million in 2021, then plummeted by 68.11% to $1.5 million in 2022, then increased by 5.74% to $1.6 million in 2023, then rose by 4.4% to $1.6 million in 2024, then fell by 26.04% to $1.2 million in 2025.
  • Its Revenue stands at $1.2 million for Q4 2025, versus $1.4 million for Q3 2025 and $749000.0 for Q2 2025.